Posted on
Thyroid cancer patients are diagnosed and evaluated by multiple physicians across many different institutions. As a result, vital communication is lost between physicians, thus hindering their ability to provide the best quality of care. Inadequate clinical communication can result in incorrect diagnoses, inappropriate surgery, incorrect disease stratification, and pathologic interpretation. Research has shown that good […]
Posted on
The recent rise in the incidence of thyroid cancer may be due to the increase in identification of low-risk papillary thyroid cancers through the use of ultrasound and/or biopsy. Most of these small, low-risk thyroid cancers (tumors < 1 cm) do not grow or grow very slowly. A new management strategy for low-risk thyroid cancers, […]
Posted on
Anaplastic thyroid cancer is a very aggressive and rare form of thyroid cancer. The US Food and Drug Administration has approved the use of Novartis’ Tafinlar (dabrafenib) and Mekinist (trametinib) administered together to treat anaplastic thyroid cancer that cannot be surgically removed or has spread to other locations in the body, and is BRAF V600E […]
Posted on
Alidad Mireskandari, Ph.D., Head of Product Development, Endocrine Business Unit at Interpace Diagnostics brings us a presentation, case studies and a Q&A.
Posted on
The TCC was honored to attend the Second Annual Thyroid Cancer Workshop at the North Shore University Hospital in Manhasset, NY 0n Saturday, June 9th. Read the story to find out more!
Posted on
The TCC will be at booth #628 at the AACE Annual Meeting this May 17-19.
Posted on
The annual Thyroid Cancer Survivor’s Workshop will be held on Saturday, June 9th in Manhasset, NY, and the TCC is extremely honored to have been invited to present to the attendees.
Posted on
We are pleased to announce that an article featuring the Thyroid Care Collaborative (TCC) has been published in the International Journal of Endocrine Oncology. The article describes all of the ways in which the TCC can be used a method of facilitating the multidisciplinary management of thyroid cancer.
Posted on
The TCC will be implementing the new AJCC staging rules into the pathology module this week.
Posted on
The TCC is happy to announce we are exhibiting at the Endocrinology and Endocrine Surgery Exhibition from December 7-9, 2017 at the Icahn School of Medicine at Mount Sinai in NY.
